These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 37141937)
1. Clinical characteristics and prognostic implications of orthopedic ligament disorders in patients with wild-type transthyretin amyloidosis cardiomyopathy. Klarskov VR; Ladefoged BT; Pedersen ALD; Hartig-Andreasen C; Clemmensen TS; Poulsen SH J Cardiol; 2023 Aug; 82(2):122-127. PubMed ID: 37141937 [TBL] [Abstract][Full Text] [Related]
2. Changes of clinical characteristics, distribution of red flags and prognosis in contemporary patients with wild-type transthyretin amyloidosis cardiomyopathy. Sanne Bøjet L; Bertil L; Anders Lehmann Dahl P; Jens Kæstel S; Tor Skibsted C; Steen Hvitfeldt P Ann Med; 2024 Dec; 56(1):2398735. PubMed ID: 39247984 [TBL] [Abstract][Full Text] [Related]
3. Where Neurosurgery Meets Heart Failure: A Case Report of a Patient with Amyloid Transthyretin Wild Type in the Ligamentum Flavum and Cardiac Tissue with Bilateral Carpal Tunnel Syndrome. Dowd RS; Nail TJ; Arkun K; Kryzanski J; Soto O; Fogaren T; Harrington K; Patel A; Comenzo R; Riesenburger RI World Neurosurg; 2019 Nov; 131():104-107. PubMed ID: 31369882 [TBL] [Abstract][Full Text] [Related]
4. Incidence and predictors of worsening heart failure in patients with wild-type transthyretin cardiac amyloidosis. Ladefoged BT; Dybro A; Dahl Pedersen AL; Rasmussen TB; Vase HØ; Clemmensen TS; Gillmore J; Poulsen SH ESC Heart Fail; 2022 Oct; 9(5):2978-2987. PubMed ID: 35733407 [TBL] [Abstract][Full Text] [Related]
5. Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy? Aus dem Siepen F; Hein S; Prestel S; Baumgärtner C; Schönland S; Hegenbart U; Röcken C; Katus HA; Kristen AV Clin Res Cardiol; 2019 Dec; 108(12):1324-1330. PubMed ID: 30953182 [TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and natural history of wild-type transthyretin amyloid cardiomyopathy in Japan. Yamada T; Takashio S; Arima Y; Nishi M; Morioka M; Hirakawa K; Hanatani S; Fujisue K; Yamanaga K; Kanazawa H; Sueta D; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Ueda M; Kaikita K; Tsujita K ESC Heart Fail; 2020 Oct; 7(5):2829-2837. PubMed ID: 32672425 [TBL] [Abstract][Full Text] [Related]
8. Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis. Kleefeld F; Scherret E; Knebel F; Messroghli D; Heidecker B; Wetz C; Schatka I; Barzen G; Tschöpe C; Amthauer H; Hahn K Amyloid; 2022 Jun; 29(2):92-101. PubMed ID: 34994254 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study. Tini G; Milani P; Zampieri M; Caponetti AG; Fabris F; Foli A; Argirò A; Mazzoni C; Gagliardi C; Longhi S; Saturi G; Vergaro G; Aimo A; Russo D; Varrà GG; Serenelli M; Fabbri G; De Michieli L; Palmiero G; Ciliberti G; Carigi S; Sessarego E; Mandoli GE; Ricci Lucchi G; Rella V; Monti E; Gardini E; Bartolotti M; Crotti L; Merli E; Mussinelli R; Vianello PF; Cameli M; Marzo F; Guerra F; Limongelli G; Cipriani A; Perlini S; Obici L; Perfetto F; Autore C; Porto I; Rapezzi C; Sinagra G; Merlo M; Musumeci B; Emdin M; Biagini E; Cappelli F; Palladini G; Canepa M Eur J Heart Fail; 2023 Jun; 25(6):845-853. PubMed ID: 36907828 [TBL] [Abstract][Full Text] [Related]
10. EstimATTR: A Simplified, Machine-Learning-Based Tool to Predict the Risk of Wild-Type Transthyretin Amyloid Cardiomyopathy. Castaño A; Heitner SB; Masri A; Huda A; Calambur V; Bruno M; Schumacher J; Emir B; Isherwood C; Shah SJ J Card Fail; 2024 Jun; 30(6):778-787. PubMed ID: 38065306 [TBL] [Abstract][Full Text] [Related]
11. Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study. Aimo A; Vergaro G; Castiglione V; Fabiani I; Barison A; Gentile F; Ferrari Chen YF; Giorgetti A; Genovesi D; Buda G; Franzini M; Piepoli M; Moscardini S; Rapezzi C; Fontana M; Passino C; Emdin M Eur J Prev Cardiol; 2024 Aug; 31(11):1410-1417. PubMed ID: 38456769 [TBL] [Abstract][Full Text] [Related]
12. Hand surgeons and amyloidosis specialists warning: transthyretin-associated amyloidosis with bifid median nerve as a cause of bilateral carpal tunnel syndrome. A case report and literature review. Triguero A; González-Costello J; López-Marne S; Llop A; Pané M; Yun S Eur J Orthop Surg Traumatol; 2022 Apr; 32(3):575-581. PubMed ID: 34050818 [TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and prognostic implications of orthopedic ligament disorders in patients with wild-type transthyretin amyloidosis cardiomyopathy. Malik GMA; Samiullah FNU; Khenhrani RR J Cardiol; 2024 Feb; 83(2):138. PubMed ID: 37783269 [No Abstract] [Full Text] [Related]
14. Prevalence, clinical significance and prognosis value of liver stiffness measurement anomalies in transthyretin cardiac amyloidosis. Lointier E; Cariou E; Beneyto M; Fournier P; Lavie-Badie Y; Eyharts D; Bureau C; Lairez O; Int J Cardiol; 2024 Dec; 416():132485. PubMed ID: 39187068 [TBL] [Abstract][Full Text] [Related]
16. Beneficial Effect of Pimobendan for Severe Heart Failure Due to Transthyretin Cardiac Amyloidosis. Okamoto N; Kubo T; Nakashima Y; Ochi Y; Takahashi A; Baba Y; Hirota T; Yamasaki N; Kitaoka H Intern Med; 2020 Feb; 59(3):339-343. PubMed ID: 31588087 [TBL] [Abstract][Full Text] [Related]
17. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. González-López E; Gallego-Delgado M; Guzzo-Merello G; de Haro-Del Moral FJ; Cobo-Marcos M; Robles C; Bornstein B; Salas C; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P Eur Heart J; 2015 Oct; 36(38):2585-94. PubMed ID: 26224076 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of wild type transtyrethin cardiac amyloidosis in a heart failure clinic. Lindmark K; Pilebro B; Sundström T; Lindqvist P ESC Heart Fail; 2021 Feb; 8(1):745-749. PubMed ID: 33205581 [TBL] [Abstract][Full Text] [Related]
19. Prevalence, Characteristics, and Impact on Prognosis of Aortic Stenosis in Patients With Cardiac Amyloidosis. Annabi MS; Carter-Storch R; Zaroui A; Galat A; Oghina S; Kharoubi M; Bezard M; Derumeaux G; Fanen P; Lemonnier F; Poullot E; Itti E; Gallet R; Teiger E; Pibarot P; Damy T; Clavel MA J Am Heart Assoc; 2024 Jul; 13(13):e034723. PubMed ID: 38904242 [TBL] [Abstract][Full Text] [Related]